In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Is Goodman Looking Beyond Japan?

Executive Summary

Japanese distributor Goodman has recently made a couple of US acquisitions. And while the products will primarily feed Goodman's Japanese pipeline, some speculate that this Jappanese powerhouse in interventional cardiology is staking out a US presence.

You may also be interested in...



FDA Shifts On Measuring Daily Limits For Excipients From Potency To Maximum Exposure

International Pharmaceutical Excipients Council of the Americas supports the maximum daily exposure limit but suggests FDA retain potency limit field until it finishes adding MDE information to avoid causing confusion.

HBW Executive Decisions: VSI And Mydecine CMOs, Branded Legacy CEO, Rooted Hemp Backs Racer

Vitamin Shoppe names Muriel Gonzalez chief merchandising and marketing officer; Branded Legacy board member Jermaine Strong replaces CEO Ryan Medico; former Red Bull marketing head Gunning joins Mydecine; and CBD edibles, topicals firm sponsors X-Games athlete.

Asia Deal Watch: Perceptive Launches LianBio With “China-Centric” Strategy

Headquartered in both China and US, the new firm will help partners bring drugs to China and other Asian markets. Novavax licenses COVID-19 vaccine in Japan to Takeda, following previous week’s deal for the vaccine in India.

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

SC141576

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel